Meeting
2021 ASCO Annual Meeting
Clinical impact of medical policy supporting universal germline testing for patients with colorectal cancer.
Authors
Sarah M. Nielsen
Invitae, San Francisco, CA
Sarah M. Nielsen , Joline Dalton , Kathryn E. Hatchell , Stacey DaCosta Byfield , Chad Moretz , John Buresh , Taryn Hall , Robert Luke Nussbaum , Edward D. Esplin
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Germline Genetic Testing
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 10514)
DOI
10.1200/JCO.2021.39.15_suppl.10514
Abstract #
10514
Abstract Disclosures
Similar Posters
Poster
2021 Gastrointestinal Cancers Symposium
The clinical and molecular characteristics of patients with personal history of colorectal cancer evaluated by cancer genetics counseling services.
First Author: Veena Krishnan
Poster
2023 ASCO Annual Meeting
A phase II study of olaparib (AZD2281) in patients (Pts) with metastatic/advanced urothelial carcinoma and other genitourinary (GU) tumors with DNA-repair defects.
First Author: Elias Chandran
Poster
2020 ASCO Virtual Scientific Program
Genomic landscape and immune phenotype of malignant pleural mesothelioma.
First Author: Meera Patel
Poster
2019 ASCO Annual Meeting
Germline multigene panel testing in colorectal cancer: Precision therapy and clinical management implications.
First Author: Edward D. Esplin